Ulcerative colitis hub
Pouchitis & Other Pouch Disorders
Last Updated Nov 11, 2025

Pouchitis is inflammation of an ileal pouch created after colectomy with ileal pouch–anal anastomosis (IPAA, often called a J‑pouch). It causes increased stool frequency, urgency, bleeding, and pelvic discomfort. Many episodes respond to short courses of antibiotics. Some people develop chronic or recurrent disease that needs advanced therapy. This article explains how pouch problems are recognized, how they are diagnosed, and the stepwise treatments from antibiotics to biologics.
Key takeaways
New or worsening urgency, bleeding, or cramping after an IPAA often signals pouch inflammation.
Pouchoscopy with biopsy is the key test to confirm pouchitis and to rule out look‑alikes.
Acute pouchitis usually improves with a 2‑week course of ciprofloxacin or metronidazole.
Chronic or antibiotic‑refractory pouchitis may need budesonide or biologics such as vedolizumab, anti‑TNF agents, or ustekinumab.
Not every pouch symptom is inflammation. Cuffitis, Crohn‑like disease of the pouch, pelvic floor issues, and small intestinal bacterial overgrowth need specific care.
What is an IPAA and why do pouch disorders happen?
After removal of the colon and rectum for ulcerative colitis, surgeons can build a pouch from the end of the small intestine and connect it to the anus. The pouch stores stool and allows bowel movements through the usual route. The new anatomy changes gut bacteria and flow. In some people, this leads to inflammation of the pouch lining. Scar tissue, muscle coordination problems, or leftover rectal tissue can also cause symptoms.
Symptoms that should prompt evaluation
More stool frequency or nighttime stools compared with the person’s usual pattern
Urgency, incontinence, or a feeling of incomplete emptying
Rectal bleeding or mucus
Lower belly or pelvic pain
Fever or fatigue
High pouch output with dehydration signs, such as dizziness or dark urine
These symptoms overlap across conditions. Testing is needed to find the cause.
How pouch problems are diagnosed
History and exam, including medication review and nonsteroidal anti‑inflammatory drug (NSAID) use
Stool tests to check for infections such as Clostridioides difficile
Blood work and sometimes fecal calprotectin (a stool marker of inflammation)
Pouchoscopy with biopsies, which is the gold standard. Endoscopic scoring tools, such as the Pouchitis Disease Activity Index, help grade severity.
Selected tests for look‑alikes: breath testing for small intestinal bacterial overgrowth, imaging for abscess or fistula, and manometry for pelvic floor dysfunction
Common pouch disorders at a glance
Pouch disorder | Key features | How it is confirmed | First‑line treatment |
|---|---|---|---|
Acute pouchitis | New urgency, bleeding, pelvic pain | Pouchoscopy with biopsy | 2 weeks of antibiotics (ciprofloxacin or metronidazole) |
Chronic antibiotic‑dependent pouchitis (CADP) | Improves on antibiotics but relapses when stopped | History plus pouchoscopy | Rotate or cycle antibiotics; consider budesonide or biologics |
Chronic antibiotic‑refractory pouchitis (CARP) | Persistent symptoms despite adequate antibiotics | Pouchoscopy showing active inflammation | Biologics such as vedolizumab, anti‑TNF therapy, or ustekinumab |
Cuffitis | Inflammation of retained rectal cuff; bleeding common | Pouchoscopy showing inflamed cuff | Topical mesalamine suppository or foam; topical steroid if needed |
Crohn‑like disease of the pouch | Prepouch ileitis, strictures, fistulas, or deep ulcers | Endoscopy and imaging | Biologics (often anti‑TNF, vedolizumab, or ustekinumab), plus surgery when needed |
Functional or mechanical issues | Outlet obstruction, pelvic floor dyssynergia, irritable pouch | Anorectal testing, imaging | Pelvic floor physical therapy, bowel retraining, antidiarrheals, biofeedback |
First‑line treatment for pouchitis
Antibiotics
Ciprofloxacin or metronidazole for about 14 days is standard for acute pouchitis.
If one is not tolerated or is ineffective, options include tinidazole or a short trial of amoxicillin‑clavulanate.
For CADP, some clinicians rotate antibiotics monthly to maintain response and limit resistance.
Anti‑inflammatory medicines
Budesonide (oral controlled‑release or topical) can induce remission when antibiotics fail or cannot be used.
Systemic prednisone is reserved for severe cases and for short courses only.
Biologics and small‑molecule therapy
For CARP or Crohn‑like disease of the pouch, vedolizumab, infliximab or adalimumab (anti‑TNF agents), and ustekinumab are commonly used.
JAK inhibitors, such as tofacitinib or upadacitinib, may be considered in select refractory cases.
Choice depends on prior drug exposure, extraintestinal symptoms, safety profile, and shared decision‑making.
Adjunctive measures
Hydration and oral rehydration solutions for high output.
Avoid NSAIDs if possible, since they can worsen symptoms.
A trial of a high‑potency probiotic may help maintain remission for some, although evidence is mixed.
Dietary steps can reduce urgency. A dietitian can guide soluble fiber, low‑fat meals, or a short low‑FODMAP trial.
Treating other pouch conditions
Cuffitis
Topical mesalamine suppositories or foams are first choice.
Topical corticosteroid foam or suppository is used if symptoms persist.
Rarely, surgery is needed for refractory cases.
Crohn‑like disease of the pouch
Treat as Crohn’s disease affecting the pouch and nearby small intestine.
Biologics are the main therapy. Abscesses need drainage. Strictures may need endoscopic dilation or surgery.
Functional and mechanical problems
Pelvic floor physical therapy and biofeedback improve coordination and emptying.
Antidiarrheals, bile acid binders, and stool‑bulking fiber are tailored to symptoms.
Treat small intestinal bacterial overgrowth with a short antibiotic course when testing or clinical suspicion supports it.
Monitoring and follow‑up
Goals are symptom control, normal activity, and healing of pouch inflammation on endoscopy.
Recheck symptoms and labs after treatment changes. If symptoms continue, repeat pouchoscopy to confirm whether inflammation is present.
Pouch cancer risk is low, but surveillance is advised for higher‑risk groups, such as those with primary sclerosing cholangitis, prior dysplasia, or long‑standing severe inflammation. Frequency is individualized with the care team.
When to seek urgent care
Fever above 101°F, severe pelvic or belly pain, or heavy bleeding
Signs of dehydration, such as dizziness, dry mouth, or very dark urine
Very high output that does not improve with oral rehydration
Inability to pass stool with increasing pain and bloating
FAQs
How soon should antibiotics work for acute pouchitis?
Many people notice improvement within a few days. If there is no change after a week, the care team may switch antibiotics or reassess the diagnosis.
Is long‑term antibiotic use safe?
Some people need cycling or low‑dose antibiotics to control symptoms. The care team monitors for side effects, such as tendon pain with ciprofloxacin or nerve tingling with metronidazole, and aims to step down when possible.
Do probiotics help prevent pouchitis?
High‑potency multi‑strain probiotics may help some individuals maintain remission, but results vary. They are an option, not a substitute for medical therapy, and should be discussed with the care team.
Can pouchitis come back years after surgery?
Yes. Risk can change over time because bacteria, diet, and immune factors shift. Early evaluation of new symptoms helps prevent complications.